Braskem: Spread normalization cut recurring EBITDA to US$382 million; leverage ended at 6.36x
1 day ago
Braskem reported a 63% quarter-over-quarter decline in recurring EBITDA to US$382 million due to normalized petrochemical spreads, while adjusted leverage rose to 6.36x.
Show all 183 updates